Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $2.46 billion. The enterprise value is $2.87 billion.
Market Cap | 2.46B |
Enterprise Value | 2.87B |
Important Dates
The next confirmed earnings date is Wednesday, November 6, 2024, after market close.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AMPH has 48.68 million shares outstanding. The number of shares has increased by 1.15% in one year.
Shares Outstanding | 48.68M |
Shares Change (YoY) | +1.15% |
Shares Change (QoQ) | -1.82% |
Owned by Insiders (%) | 8.49% |
Owned by Institutions (%) | 72.93% |
Float | 37.69M |
Valuation Ratios
The trailing PE ratio is 16.07 and the forward PE ratio is 12.50. AMPH's PEG ratio is 0.88.
PE Ratio | 16.07 |
Forward PE | 12.50 |
PS Ratio | 3.45 |
Forward PS | 2.92 |
PB Ratio | 3.49 |
P/FCF Ratio | 13.88 |
PEG Ratio | 0.88 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.12, with an EV/FCF ratio of 16.14.
EV / Earnings | 17.26 |
EV / Sales | 4.03 |
EV / EBITDA | 10.12 |
EV / EBIT | 12.36 |
EV / FCF | 16.14 |
Financial Position
The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.87.
Current Ratio | 3.52 |
Quick Ratio | 2.55 |
Debt / Equity | 0.87 |
Debt / EBITDA | 2.14 |
Debt / FCF | 3.48 |
Interest Coverage | 7.18 |
Financial Efficiency
Return on equity (ROE) is 25.57% and return on invested capital (ROIC) is 11.86%.
Return on Equity (ROE) | 25.57% |
Return on Assets (ROA) | 10.13% |
Return on Capital (ROIC) | 11.86% |
Revenue Per Employee | $404,822 |
Profits Per Employee | $94,557 |
Employee Count | 1,761 |
Asset Turnover | 0.50 |
Inventory Turnover | 2.82 |
Taxes
In the past 12 months, AMPH has paid $35.12 million in taxes.
Income Tax | 35.12M |
Effective Tax Rate | 17.42% |
Stock Price Statistics
The stock price has increased by +13.46% in the last 52 weeks. The beta is 0.83, so AMPH's price volatility has been lower than the market average.
Beta (5Y) | 0.83 |
52-Week Price Change | +13.46% |
50-Day Moving Average | 48.22 |
200-Day Moving Average | 45.28 |
Relative Strength Index (RSI) | 62.35 |
Average Volume (20 Days) | 264,811 |
Short Selling Information
The latest short interest is 4.23 million, so 8.70% of the outstanding shares have been sold short.
Short Interest | 4.23M |
Short Previous Month | 4.35M |
Short % of Shares Out | 8.70% |
Short % of Float | 11.23% |
Short Ratio (days to cover) | 13.18 |
Income Statement
In the last 12 months, AMPH had revenue of $712.89 million and earned $166.52 million in profits. Earnings per share was $3.15.
Revenue | 712.89M |
Gross Profit | 392.51M |
Operating Income | 232.59M |
Pretax Income | 201.63M |
Net Income | 166.52M |
EBITDA | 284.16M |
EBIT | 232.59M |
Earnings Per Share (EPS) | $3.15 |
Balance Sheet
The company has $217.78 million in cash and $620.58 million in debt, giving a net cash position of -$402.81 million or -$8.28 per share.
Cash & Cash Equivalents | 217.78M |
Total Debt | 620.58M |
Net Cash | -402.81M |
Net Cash Per Share | -$8.28 |
Equity (Book Value) | 713.35M |
Book Value Per Share | 14.57 |
Working Capital | 345.67M |
Cash Flow
In the last 12 months, operating cash flow was $212.60 million and capital expenditures -$34.47 million, giving a free cash flow of $178.13 million.
Operating Cash Flow | 212.60M |
Capital Expenditures | -34.47M |
Free Cash Flow | 178.13M |
FCF Per Share | $3.66 |
Margins
Gross margin is 55.06%, with operating and profit margins of 32.63% and 23.36%.
Gross Margin | 55.06% |
Operating Margin | 32.63% |
Pretax Margin | 28.28% |
Profit Margin | 23.36% |
EBITDA Margin | 39.86% |
EBIT Margin | 32.63% |
FCF Margin | 24.99% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.15% |
Shareholder Yield | -1.15% |
Earnings Yield | 6.74% |
FCF Yield | 7.21% |
Analyst Forecast
The average price target for AMPH is $63.00, which is 24.68% higher than the current price. The consensus rating is "Buy".
Price Target | $63.00 |
Price Target Difference | 24.68% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 15.88% |
EPS Growth Forecast (5Y) | 26.03% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 3.6 and a Piotroski F-Score of 6.
Altman Z-Score | 3.6 |
Piotroski F-Score | 6 |